Little Leaves Behavioral Services Opens Two New Locations in Maryland
ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with...
ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with...
ABA therapy centers in Middle River and Owings Mills expand access to high-quality, early intervention services for young children with...
TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital...
GARDEN CITY, N.Y., July 25, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
NEW YORK, July 24, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from...
Board brings together diverse industry veterans representing insurers, educators, clinicians and healthcare providers to ensure a robust, practical approach to...
Tel Aviv, July 22, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical...
GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a...
Winter Park, Florida--(Newsfile Corp. - July 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine,...
Company highlights its AI referral innovation, projected growth, expanded public sector alliances, and position as a ServiceNow Service Provider Partner...
Many Groups and Organizations respond to Policy Issues WASHINGTON, July 10, 2025 /PRNewswire/ -- The recent rapid approach to policy...
SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- TalentLMS, the leading employee training platform, is driving a new era of social...
To discuss the unmet medical need in Borderline Personality Disorder (BPD) and the design of vafidemstat’s Phase III PORTICO-2 trial...
KANSAS CITY, Mo.--(BUSINESS WIRE)--#AIinHealthcare--Trially®, a breakthrough AI clinical trial recruitment technology to unlock faster qualified patient enrollment, today announced the...
Milestone recognition, mentorship, and advancement opportunities come together as part of the Career Compass initiative CONCORD, Calif., June 2, 2025...
LOS ANGELES, June 10, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve...
Dr. Gül Dölen, MD, PhD, to share groundbreaking research on how psychedelic compounds can reopen “critical periods” of brain plasticity....
LOS ANGELES, June 10, 2025 /PRNewswire/ -- Public Television audiences are invited to discover a refreshing perspective on educational possibilities...
Collaborative Advocacy Responds to Swift Federal and State Policy Shifts WASHINGTON, May 8, 2025 /PRNewswire/ -- Access Ready Strategic, a national...